Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Bioconjugation Market Size And Revenue Outlook Through 2030
The bioconjugation market has experienced swift expansion in recent years. Its value is projected to climb from $6.12 billion in 2025 to $6.89 billion in 2026, registering a compound annual growth rate (CAGR) of 12.5%. Historically, this expansion was driven by factors such as intensifying biologics research activities, the broadened application of antibody-based therapeutics, advancements in diagnostic assay development, the increasing embrace of protein labeling techniques, and the accessibility of standardized conjugation kits.
The bioconjugation market size is anticipated to experience significant expansion in the coming years. It will grow to $11.12 billion in 2030 at a compound annual growth rate (CAGR) of 12.7%. This growth during the forecast period can be attributed to the increasing development of targeted drug conjugates, rising investments in precision medicine research, the expansion of companion diagnostics, the growing use of conjugated biomolecules in imaging, and an increasing demand for scalable conjugation workflows. Key trends expected in the forecast period include the increasing adoption of site-specific conjugation techniques, a rising use of advanced linker chemistries, a growing demand for high-purity conjugation reagents, the expansion of automated conjugation platforms, and an enhanced focus on stability and reproducibility.
Get A Free Sample Report With In-Depth Market Insights:
Bioconjugation Market Growth Momentum: What Factors Are Shaping Demand?
The escalating requirement for targeted therapeutics is anticipated to fuel the expansion of the bioconjugation market in the future. These therapeutics are medical interventions specifically engineered to pinpoint disease-causing cells or molecules, thereby boosting treatment effectiveness and reducing harm to healthy tissues. The surge in targeted therapeutics stems from a growing need for precision medicine, which facilitates more accurate treatment strategies leading to improved patient results and fewer negative side effects. Bioconjugation aids targeted therapeutics by allowing for the exact attachment of drugs to specific targeting molecules, which enhances selective delivery to diseased cells and boosts therapeutic potency. An illustration of this trend is seen in February 2024, where data from the West China Hospital, Sichuan University, a medical research center in China focused on targeted therapies, indicated that more than 47 novel targeted therapeutics gained approval from the U.S. Food and Drug Administration in 2023. These approvals constituted approximately 85.5% of all new drug approvals, highlighting a growing focus on precision-targeted treatment options within the United States. Consequently, the heightened need for targeted therapeutics is acting as a primary catalyst for the expansion of the bioconjugation market.
Bioconjugation Market Segment Analysis And Revenue Potential
The bioconjugation market covered in this report is segmented –
1) By Product And Service: Consumables; Instruments; Service
2) By Biomolecule Type: Antibodies; Proteins; Peptides; Oligonucleotides; Other Biomolecules
3) By Technique: Chemical Conjugation; Enzyme-Mediated Conjugation; Click Chemistry; Photoreactive Crosslinking; Other Techniques
4) By Application: Therapeutics; Research And Development; Diagnostics
5) By End Use: Pharmaceutical And Biotechnology Companies; Contract Research Organizations (CRO) And Contract Manufacturing Organizations (CMOs); Academic And Research Institutes; Hospitals, Clinical And Diagnostic Laboratories
Subsegments:
1) By Consumables: Reagents; Buffers; Linkers; Kits; Resins; Chromatography Materials; Protein Purification Materials
2) By Instruments: Chromatography Systems; Spectroscopy Systems; Electrophoresis Systems; Automated Conjugation Platforms; Imaging Systems; Bioreactors
3) By Service: Custom Conjugation Services; Antibody Modification Services; Protein Labeling Services; Contract Research Services; Analytical Testing Services; Purification Services
Bioconjugation Market Trends Redefining Industry Growth
Leading companies in the bioconjugation market are prioritizing the creation of advanced platforms, such as site-specific conjugation methods, with the aim of refining drug delivery precision, boosting coupling stability, and reducing off-target toxicity. Site-specific conjugation methods are defined as bioconjugation techniques that enable precise linkage of therapeutic molecules, for example, drugs or RNAi, to biomolecules including antibodies, peptides, or oligonucleotides, thereby guaranteeing consistent activity and safety. An example illustrating this occurred in August 2023, when BOCSCI Inc., a US-based supplier of research chemicals and bioconjugation services, introduced the XDC bioconjugation platform, a cutting-edge solution intended to enhance the creation of bioconjugates. Utilizing advanced conjugation strategies, comprising unnatural amino acid incorporation, engineered cysteine conjugation, enzyme-assisted ligation, and glycoconjugation generation, this platform facilitates the accurate production of antibody-drug conjugates, siRNA conjugates, and other targeted drug delivery molecules, ultimately enabling researchers to develop safer and more effective biopharmaceuticals.
Bioconjugation Market Competitive Overview And Top Companies
Major companies operating in the bioconjugation market are Thermo Fisher Scientific Inc., Merck KGaA, Danaher Corporation, Lonza Group AG, Agilent Technologies Inc., Charles River Laboratories International Inc., Sartorius AG, Bio-Rad Laboratories Inc., Vector Laboratories Inc., Promega Corporation, LGC Biosearch Technologies Ltd., TriLink BioTechnologies LLC, Creative PEGWorks Inc., Lumiprobe Corporation, Biotium Inc., Jena Bioscience GmbH, Quanta BioDesign Ltd., Setareh Biotech Inc., Baseclick GmbH, Biosynth Carbosynth Ltd., Glen Research Inc., BroadPharm Inc., and Biorbyt Ltd.
View The Full Bioconjugation Market Report:
Bioconjugation Market Leading Geography: Which Region Contributes The Most Revenue?
North America was the largest region in the bioconjugation market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bioconjugation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model